Skip to Content

News: Women’s Cancers

Another way to detect lymphedema

Tuesday, October 22nd, 2019

Early detection of lymphedema, which occurs in 20% of patients following breast cancer treatment, may improve therapeutic options for patients.

Effort seeks to enhance cancer screening for Hispanic/Latina women

Wednesday, September 25th, 2019

Providing access to a culturally appropriate community health worker during breast cancer screenings may impact elements of patient care and satisfaction among Hispanic/Latina women.

Study tests new vaccine for precancerous cervical cells

Wednesday, December 12th, 2018

Vanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeutic vaccine for treating women with precancerous changes on the cervix.

Velez Edwards named to Women’s Health Research leadership

Monday, July 2nd, 2018

Digna R. Velez Edwards, PhD, has been named director of Women’s Health Research, succeeding longtime director and founder, Katherine Hartmann, MD, PhD, associate dean of Clinical and Translational Scientist Development and professor of Obstetrics and Gynecology.

VICC leads study on high breast cancer incidence and mortality rates in African-American women

Wednesday, July 6th, 2016

A cancer research consortium headed by investigators at Vanderbilt-Ingram Cancer Center (VICC) and two other institutions, today received $12 million in federal funding to help determine why African-American women die at a higher rate and have more aggressive breast cancer than white women.  The grant, which was awarded by the National Cancer Institute (NCI), part […]

Alvarez named chair of Obstetrics and Gynecology

Friday, May 6th, 2016

Ronald David Alvarez, M.D., Ellen Gregg Shook Culverhouse Chair in the Division of Gynecologic Oncology and vice chair of the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham, has been named chair of the Department of Obstetrics and Gynecology at Vanderbilt University Medical Center. His appointment is effective Sept. 1. Alvarez […]

Vanderbilt-Ingram Cancer Center Encourages HPV Vaccination

Wednesday, January 27th, 2016

Contact: Dagny Stuart, (615) 936-7245 In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in urging increased HPV vaccination for the prevention of cancer. Experts at VICC, in collaboration with colleagues at the other cancer centers, recognize […]

VICC investigators land Komen breast cancer grants

Thursday, October 1st, 2015

Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research. The 2015 grants will provide nearly […]

Ovarian cancer foundation honors VUMC’s Khabele

Thursday, September 24th, 2015

Dineo Khabele, M.D., associate professor of Obstetrics and Gynecology and Cancer Biology, has been named to the Scientific Advisory Committee of the Ovarian Cancer Research Fund (OCRF). Khabele joins Celeste Leigh Pearce, Ph.D., MPH, associate professor in the Department of Epidemiology at the University of Michigan, and Daniel Powell Jr., Ph.D., research associate professor of […]

Drug combos enhance ovarian cancer cell death

Monday, August 24th, 2015

Ovarian cancer is often diagnosed at an advanced stage and frequently develops resistance to platinum chemotherapy. Identifying new drug combinations to overcome platinum resistance is a critical clinical challenge. They report in the Journal of Ovarian Research that combined thymoquinone and cisplatin had synergistic anti-tumor effects in cultured cells. The drug combination reduced tumor burden and […]

Next Page »